Tumour Suppressor Genes
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
... in tumour behaviour and responsiveness to ...of genes that are seemingly downregulated in unfavourable tumours, ...potential tumour suppressor ...compare tumour tissue to its ...
13
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
... tumour suppressor genes in previous studies is driven by the exact location of a gene in the ...selected genes that are located not in the smallest region, but in the most common region, which ...
7
A study of the role of oncogenes and tumour suppressor genes in malignant pancreatico-biliary tumours
... and tumour suppressor genes is still awaited in the clinical ...and tumour suppressor genes which control cell proliferation are also implicated in programmed cell death and ...
382
No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer
... Stephen B Fox* - [email protected] * Corresponding author Abstract Background: Succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tricarboxylic acid (TCA) cycle enzymes that are also known to act as ...
8
NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines
... In eukaryote cells, mRNAs molecules that contain prema- ture termination codons (PTCs) due to nonsense muta- tions are detected and rapidly degraded by the nonsense- mediated decay (NMD) mechanism. NMD is mediated ...
13
Rabaptin-5 and Rabex-5 are neoplastic tumour suppressor genes that interact to modulate Rab5 dynamics in Drosophila melanogaster
... endocytic tumour suppressor genes have already been identi fi ed in Drosophila, screens have not been saturating and it is likely that many remain ...neoplastic tumour suppressor gene: ...
16
IMMUNOHISTOCHEMISTRY OPTIMISATION OF SOME TUMOUR SUPPRESSOR GENES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASED FORMALIN FIXED PARAFFIN EMBEDDED TISSUE SECTIONS.
... expressing tumour suppressor genes such as p53, particularly in studies for lung ...following tumour suppressor genes; p53, TTC5, Bax and p21 genes on COPD tissue ...
8
Study of tumour suppressor genes in malignant tumours of liver, pancreas and biliary system
... 5.2 Patients and analysis Due to the rarity of the condition, in the past three years I was able to collect five patients with fibrolamellar carcinoma who underwent surgical resection of their tumours at Hammersmith or ...
330
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
... or genes that still remain to be ...display tumour-specific biallelic NF2 inactivation, could, in principle, be caused by mutations in hitherto unidentified ...unidentified genes could be even ...
20
Comparative analysis of germline and somatic micro-lesion mutational spectra in 17 human tumour suppressor genes
... How do germline and somatic mutational spectra for each o f the studied human tumour suppressor gene compare with respect to the relative proportions of each type of mutation (i.e. mis[r] ...
292
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
... detect genes mutated in RCC (Dalgliesh et al 2010), epigenetic studies have identified at least 18 genes that are inactivated in >20% of RCC (Morris et ...of genes to exclude those that were not ...
28
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
... detect genes mutated in RCC (Dalgliesh et al 2010), epigenetic studies have identified at least 18 genes that are inactivated in >20% of RCC (Morris et ...of genes to exclude those that were not ...
29
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer
... higher tumour stages, as NIM levels increased with local tumour progression in ...where tumour characteristics like size and differentiation, but not the nodal status, differed according to the ...
7
Analysis of gene rearrangements and protein expression of the tumour suppressor genes, RB1 and p16, in acute myeloid leukaemia: Possible roles in leukaemogenesis
... in tumour cell population has been shown to occur using histochemical studies of human sarcomas in which 40% of the tumours analysed showed heterogeneity in the RB protein expressed (Cance ...
209
Identification and characterisation of candidate tumour suppressor genes from chromosome 13q14.3, an area of frequent deletion in patients with B-cell chronic lymphocytic leukaemia
... deletion described by most groups so far and is unlikely to be the tumour suppressor gene involved in the pathogenesis of B-cell CLL. Another group reported screening of 322 cases of B-cell CLL and 30 cases ...
260
Characterization of a tumour suppressor function of RanBPM
... of tumour suppressor genes, and are often mutated or inactivated in cancer ...potential tumour suppressor role for RanBPM arises from the observation that RanBPM is a critical ...
205
The 5S RNP and the regulation of the tumour suppressor
... However, it still remains unclear as to whether the defects in 5S RNP ribosomal integration are caused purely by ribosome biogenesis defects or whether these proteins play a direct rol[r] ...
224
Oncogenes and Tumor Suppressor Genes
... 1989 - Michael Bishop and Harold Varmus , on the basis of the previous discovery, demonstrated that the viral v-src ONCOGENE derives from a normal gene already present in the vertebr[r] ...
24
Studies of the PTEN tumour suppressor in endometrial cancer
... 1.6 Project Aims Overview Endometrial carcinoma is the most common gynaecological malignancy and has the highest rate of PTEN mutation over any other cancer. Over 100 mutations have been described, but none of the ...
385
The multifaceted von Hippel–Lindau tumour suppressor protein
... and how its loss contributes to cancer pathogenesis. However, the full extent of pVHL’s tumour suppressive contribution is not fully understood and this remains an area of active research. To date, anti-tumor ...
8